Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CEO
The post Roche’s Genentech agrees to buy Jecure Therapeutics appeared first on Pharmaceutical Business review.
Original Article: Roche’s Genentech agrees to buy Jecure Therapeutics